Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region)

Prostate

Volumn 39, Issue 4, 1999, Pages 316-322

  Kranse, Ries ^a   Beemsterboer, Petra ^b   Rietbergen, John ^a   Habbema, Dik ^b   Hugosson, Jonas ^c   Schröder, Fritz H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biopsy; DRE; Logistic regression; Prostate cancer; PSA; TRUS

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; EUROPE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY; EUROPE; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; PALPATION; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM;

EID: 0345643330     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990601)39:4<316::AID-PROS14>3.0.CO;2-O     Document Type: Article

References (15)

1. Auvinen A, Calais da Silva F, Denis LJ, Hugosson J, Schröder FH. The European Randomised Study of Screening for Prostate Cancer (ERSPC): international co-operation and preliminary data. New York: Parthenon; 1996. p 167-172.
2. Rietbergen JB, Kranse R, Kirkels WJ, De Koning HJ, Schröder FH. Evaluation of prostate-specific antigen, digital rectal examination and transrectal ultrasonography in population-based screening for prostate cancer: improving the efficiency of early detection. Br J Urol [Suppl] 1997;79:57-63.
3. Rietbergen JB, Kruger AE, Kranse R, Schröder FH. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997;49:875-880.
4. Beemsterboer PMM, Kranse R, de Koning HJ, Habbema JWF, Schröder FH. Changing role of 3 screening modalities, from a public health perspective: European Randomised Study of Screening for Prostate Cancer (Rotterdam). 1997. Int J Cancer 1999; in press.
5. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-1557, 1564.
6. Giovannucci E, Tosteson TD, Speizer FE, Ascherio A, Vessey MP, Colditz GA. A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA 1993;269:878-882.
7. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992;147:817-821.
8. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-816.
9. Kalish J, Cooner WH, Graham SD Jr. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 1994;43:601-606.
10. Oesterling JE, Jacobsen SJ, Cooner WH. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older. J Urol 1995;153:1160-1163.
11. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993;150:797-802.
12. Anderson JA. Separate sample logistic discrimination. Biometrika 1972;59:19-35.
13. Mettlin C, Lee F, Drago J, Murphy GP. The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer 1991; 67:2949-2958.
14. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL, Emond J. Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 1992;147:846-852.
15. Daneshgari F, Taylor GD, Miller GJ, Crawford ED. Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies. Urology 1995;45:604-609.